Patenting and strategies of major pharmaceutical companies in Brazil
DOI:
https://doi.org/10.33448/rsd-v9i9.6896Keywords:
Strategies; Indicators; Pharmaceutical industry; Patents.Abstract
Facing the contemporaneous changes which have intensified the market competition, survival strategies are essential for the company sustainability, such as the protection of intangible assets through the patents, which confer several advantages. In the pharmaceutical industry, where the products are result from expensive processes, the patents have become an important incentive. This article has undertaken a systematic analysis of patenting in the Brazilian pharmaceutical industry, evaluating the patents indicators of the major pharmaceutical companies in Brazil in order to categorize their strategies. The results indicated the leadership of Aché in patent applications, an extremely small number of concessions, characterizing the majority of the deposits as Invention Patents, and the lack of partnerships with universities and /or foundations for research support. The EMS and Eurofarma companies have presented analytical strategic performance, the União Química, defender, and Aché and Hypermarcas, prospector performance.
References
Carvalho, D S, Oliveira, L G, Winter, E, & Mothé, C G. (2009). Technological foresight based on citing and cited patents of cellulose with pharmaceutical applications. Journal of Technology Management & Innovation, 4(4), 32-41, doi: 10.4067/S0718-27242009000400003.
Chen, Y S, & Chang, K C. (2010). The relationship between a firm's patent quality and its market value - The case of US pharmaceutical industry. Technological Forecasting and Social Change, 77(1), 20-33, doi: 10.1016/j.techfore.2009.06.003.
Conferência Nacional da Indústria. Propriedade Intelectual: as mudanças na indústria e a nova agenda. 2014. [access in 10 may 2018]. Available in: http://arquivos.portaldaindustria.com.br/app/conteudo_24/2014/07/22/484/V39_Propriedadeintelectual_web.pdf.
Ernst, H. (2003). Patent information for strategic technology management. World Patent Information, 25(3), 233-242, doi: 10.1016/S0172-2190(03)00077-2.
Exame. (2014). As 10 maiores indústrias farmacêuticas do país em 2014. 2015. [access in 10 jul 2017]. Disponível em: https://exame.com/negocios/as-10-maiores-industrias-farmaceuticas-do-pais-em-2014/.
Figueiredo, A P C G. (2010). Indústria farmacêutica e a proteção de patentes: o embate entre o desenvolvimento econômico e o social. Âmbito Jurídico, 13.
Florêncio, M N S, Abud, A K S, Costa, B M G & Oliveira Jr, A M. (2020). Analysis of biotechnology production and collaboration in brazil. Research, Society and Development, 9(7): 1-27, e448974362.
Jungmann, D M, & Bonetti, E A. (2010). A caminho da inovação: proteção e negócios com bens de propriedade intelectual: guia para o empresário. IEL, Brasília.
IMS Institute. The Global Use of Medicines: Outlook Through 2016. 2017. [access in 1 jan 2018]. Retirado de: https://www.imshealth.com/files/web/IMSH%20Institute/Reports/ The%20Global%20Use%20of%20Medicines%20Outlook%20Through%202016/Medicines_Outlook_Through_2016_Report.pdf
Miles, R E, Snow C C, Meyer A D, & Coleman H J. (1978). Organizational strategy, structure, and process. Academy of Management Review, 3(3), 546–562.
Novaretti, M C Z, Aquino, S, & Piscopo, M R. (2014). Controle de vendas de antibióticos no Brasil: Análise do efeito dos atos regulatórios no uso abusivo pelos consumidores. Revista Acadêmica São Marcos, 4(2), 25-39.
Oliveira, L G, Carestiato, T, Mothé, C G, & Souza, R V. (2010). Technological monitoring study based on invention patents of omeprazole and derivatives with pharmaceutical applications. Journal of Technology Management & Innovation, 5(3), 110-119, doi: 10.4067/S0718-27242010000300008.
Peralta, P P, Silva, E F, Fierro, I M, & Teruya, D Y. (2014). Panorama do uso de marcas pelos grandes laboratórios farmacêuticos multinacionais no mercado brasileiro. RECIIS – Revista Eletrônica de Comunicação, Informação & Inovação em Saúde, 8(1), 20-31, doi: 10.3395/reciis.v8i1.487.
Pereira, A S et al. (2018). Metodologia da pesquisa científica. [e-book]. Santa Maria. Ed. UAB/NTE/UFSM. Acesso em: 9 maio 2020. Retirado de: https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1
Pereira, J M. (2011). A gestão do sistema de proteção à propriedade intelectual no Brasil é consistente? Revista de Administração. Pública, 45(3), 567-590, doi: 10.1590/S0034-76122011000300002.
Piscopo, M R. (2010). Empreendimento corporativo e competitividade em empresas de base tecnológica. Revista de Administração e Inovação, 7(1), 131-150.
Quintella, C M, & Teodoro, A F O. (2013). Os ganhos econômicos diante da Propriedade Intelectual: retorno do investimento à sociedade. Simpósio de Excelência em Gestão e Tecnologia, Rio de Janeiro.
Sztulwark, S, & Juncal, S. (2014). Innovación y producción en la industria manufacturera: Estudio comparativo de cadenas globales. Journal of Technology Management & Innovation, 9(4), 119-131, doi: 10.4067/S0718-27242014000400009.
Scopel, F, Gregolin, J A R, & Faria, L I L. (2013). Tendências tecnológicas do uso do sisal em compósitos a partir da prospecção em documentos de patentes. Polímeros, 23(4), 514-520, doi: 10.4322/polimeros.2013.044.
Vargas, M, Gadelha, C A G; Costa, L S; & Maldonado, J. (2012). Inovação na indústria química e biotecnológica em saúde: em busca de uma agenda virtuosa. Revista de Saúde Pública, 46(1), 37-40, doi: 10.1590/S0034-89102012000700006.
Weenem, T C, Pronker, E S, Commandeur, H R, & Claassen, E. (2013). Patenting in the European medical nutrition industry: Trends, opportunities and strategies. PharmaNutrition, 1(1), 13-21, doi: 10.1016/j.phanu.2012.10.003.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Ana Karla Abud, Gláucia Rocha Acioli, Antonio Martins Oliveira Júnior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
